376270 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
HEM Pharma, Inc. engages in the provision of microbiome solutions. Its products and services include customized healthcare and live biotherapeutic products (LBP) discovery platform services, myLAB, phytobiome, technology transfer, microbiome analysis, and phytochemical solutions. The company was founded on December 30, 2016 and is headquartered in Pohang-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
376270 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company